MARCH 27
Days
- :
Hrs
- :
Min
- :
Sec
ePoster Gallery
P017: Is Tumor PD-L1 Expression Predictive of Response after Neoadjuvant Chemoimmunotherapy in Triple Negative Inflammatory Breast Cancer?
Jennifer Chen
The University of Texas MD Anderson Cancer Center
P018: Local control after preoperative radiotherapy + immune checkpoint blockade and surgical resection is mediated by CD8 T cells – a murine breast tumor model to reverse translate the local treatment effects of NCT04454528
Julia Tchou MD PhD FACS
University of Pennsylvania
P019: Long-term safety of prophylactic and therapeutic nipple sparing mastectomies in BRCA1 and BRCA2 mutation carriers
Denise Garcia MD, MEd
Massachusetts General Brigham
P020: Omission of radiation after breast conserving surgery for invasive lobular carcinoma: impact on early recurrence events in patients meeting PRIME II criteria
Mandeep Kaur
University of California, San Francisco
P021: Pathologic Complete Response and Survival after Neoadjuvant Endocrine Therapy Among Racial Groups in Hormone Receptor-Positive Breast Cancer
Selena An MD, MSPH, MA
University of North Carolina
P022: Post-Operative Impact of Negative Pressure Wound Therapy Following Oncoplastic Breast Surgery
Nicole Harris
P023: Residential Proximity to National Priorities List Superfund Sites and Exposure to Poor Air Quality Are Associated with Increased Likelihood of Triple Negative Breast Cancer in a South Florida Population
Peter Borowsky
University of Miami
P024: Surgeon Practice Patterns in De Novo Oligometastatic Breast Cancer
Malia Brennan MD
University of Washington
P025: Survival in Older Women Receiving Adjuvant Radiation Monotherapy vs. Endocrine Monotherapy Following Lumpectomy for Invasive Breast Cancer
Tori Chanenchuk
Duke University
P026: The Impact of Neoadjuvant Immunotherapy on Lymphedema Rates in Triple Negative Breast Cancer Following Axillary Surgery
Sarah Kelly
Memorial Sloan Kettering (via University College Dublin)
P027: The Role of Neutrophil in Breast Tumor Microenvironment and Association with Response to Neoadjuvant Therapy.
Faisal Jehan MD, FICS.
Roswell Park Comprehensive Cancer Center
P028: Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB): De-escalation of Axillary Surgery in Favor of Radiation
Marissa Boyle MD
Cedars-Sinai Medical Center
P029: Tumor antigen targeting type 1 conventional dendritic cells drive immune responses to eliminate metastasis initiating cancer cells
Caitlyn Balsay-Patel MD
Moffitt Cancer Center
P030: Tumor hypoxia is associated with markers of increased tumor aggression and response to immunotherapy in ER+/HER2- breast cancer patients
Olivia Martin MD, MS
Roswell Park Comprehensive Cancer Center
P031: Use of Neoadjuvant Chemotherapy for Local and Regionally Recurrent Triple Negative and HER2+ Breast Cancer
Mary Mrdutt
Mayo Clinic
P032: Variation in Locoregional Surgical Management of Stage IV Breast Cancer; Local/Institutional and Regional Geographic Considerations
Shruti Zaveri
The University of Texas Southwestern Medical Center
P033: A Low Cost Endoluminal Vacuum Therapy for Rectal Anastomotic Leaks in a Resource Constraint Setting : Outcomes and Insights of a Single Centre Experience
John Alapatt MS (General surgery), DrNB (Surgical Oncology), FEBS, MRCS (Edinburgh)
MVR CANCER CENTRE AND RESEARCH INSTITUTE
P034: A NOVEL ROLE OF SECRETED METHIONINE ADESNOSYLTRANSFERASE a2 IN THE DEVELOPMENT OF COLORECTAL LIVER METASTASES
Monica Justo MD
Cedars Sinai Medical Center